Bruno Lina

Bruno Lina's AcademicInfluence.com Rankings

Bruno Lina

Philosophy

#7836

World Rank

#11102

Historical Rank

Logic

#4871

World Rank

#6203

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Bruno Lina Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bruno Lina's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Clinical and virological data of the first cases of COVID-19 in Europe: a case series (2020) (946)
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020 (2020) (471)
Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season (2009) (416)
SARS-CoV-2 variants and ending the COVID-19 pandemic (2021) (374)
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates (2020) (262)
The Impact of Dual Viral Infection in Infants Admitted to a Pediatric Intensive Care Unit Associated with Severe Bronchiolitis (2008) (249)
Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020 (2020) (223)
Type I IFN immunoprofiling in COVID-19 patients (2020) (218)
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia (2020) (191)
Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020 (2020) (175)
Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. (2008) (173)
A supramolecular assembly formed by influenza A virus genomic RNA segments (2011) (172)
Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020. (2020) (169)
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial (2021) (168)
First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. (2013) (167)
Rhinoviruses delayed the circulation of the pandemic influenza A (H1N1) 2009 virus in France. (2010) (161)
Sequencing of 'untypable' enteroviruses reveals two new types, EV-77 and EV-78, within human enterovirus type B and substitutions in the BC loop of the VP1 protein for known types. (2003) (145)
Surveillance of community-acquired viral infections due to respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995 (1996) (142)
Mixed Respiratory Virus Infections (2008) (133)
Immunogenicity and efficacy of heterologous ChAdOx1–BNT162b2 vaccination (2021) (132)
Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France. (2014) (129)
Surveillance of enteroviruses in France, 2000–2004 (2007) (128)
Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. (2015) (127)
Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial (2010) (119)
Pandemic A(H1N1)2009 influenza virus detection by real time RT-PCR: is viral quantification useful? (2010) (116)
Microbiological disinfection of water and air by photocatalysis (2007) (115)
A functional sequence-specific interaction between influenza A virus genomic RNA segments (2013) (115)
Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS (2000) (110)
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis (2022) (110)
Ten years of human metapneumovirus research. (2012) (109)
An in vitro network of intermolecular interactions between viral RNA segments of an avian H5N2 influenza A virus: comparison with a human H3N2 virus (2012) (101)
Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). (2013) (99)
Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation (2020) (95)
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2 (2020) (95)
Association of respiratory picornaviruses with acute bronchiolitis in French infants. (2006) (91)
Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors. (2008) (90)
European surveillance for enterovirus D68 during the emerging North-American outbreak in 2014. (2015) (90)
Functional balance between neuraminidase and haemagglutinin in influenza viruses. (2016) (90)
Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice. (2005) (89)
Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses (2013) (89)
High Risk HPV Contamination of Endocavity Vaginal Ultrasound Probes: An Underestimated Route of Nosocomial Infection? (2012) (88)
PAR1 contributes to influenza A virus pathogenicity in mice. (2013) (88)
Multicenter evaluating of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens (1996) (87)
Genetic classification of “Sapporo-like viruses” (2001) (86)
Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses. (2008) (86)
Risk of influenza-like illness in an acute health care setting during community influenza epidemics in 2004-2005, 2005-2006, and 2006-2007: a prospective study. (2011) (84)
Routes of transmission during a nosocomial influenza A(H3N2) outbreak among geriatric patients and healthcare workers. (2014) (84)
Incidence of Upper Respiratory TractMycoplasma pneumoniae Infections among Outpatients in Rhône-Alpes, France, during Five Successive Winter Periods (1999) (83)
Human parechovirus infections, Lyon, France, 2008-10: evidence for severe cases. (2012) (82)
Clinical Characteristics Are Similar across Type A and B Influenza Virus Infections (2015) (81)
Impact of the 2009 influenza A(H1N1) pandemic wave on the pattern of hibernal respiratory virus epidemics, France, 2009. (2010) (80)
Interaction network linking the human H3N2 influenza A virus genomic RNA segments. (2012) (79)
Combining High-Resolution Contact Data with Virological Data to Investigate Influenza Transmission in a Tertiary Care Hospital (2015) (78)
Cold oxygen plasma technology efficiency against different airborne respiratory viruses. (2009) (78)
New enteroviruses, EV‐93 and EV‐94, associated with acute flaccid paralysis in the Democratic Republic of the Congo (2007) (78)
Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016 (2016) (77)
Phenotypic and Genetic Characterization of Thymidine Kinase from Clinical Strains of Varicella-Zoster Virus Resistant to Acyclovir (1999) (77)
Dermatological Spectrum of Hand, Foot and Mouth Disease from Classical to Generalized Exanthema (2014) (76)
Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? (2021) (75)
Clotting activity in Staphylococcus schleiferi subspecies from human patients (1994) (74)
Development of a real-time PCR procedure including an internal control for the measurement of HCMV viral load. (2001) (74)
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs (2021) (73)
Dual infections by influenza A/H3N2 and B viruses and by influenza A/H3N2 and A/H1N1 viruses during winter 2007, Corsica Island, France. (2008) (72)
Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study (2018) (72)
Plasminogen Controls Inflammation and Pathogenesis of Influenza Virus Infections via Fibrinolysis (2013) (72)
Postpolio syndrome: poliovirus persistence is involved in the pathogenesis (1999) (69)
Epidemiology of human enterovirus 71 infections in France, 2000-2009. (2011) (68)
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France (2021) (68)
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021 (2021) (67)
Influenza vaccination of healthcare workers in acute-care hospitals: a case-control study of its effect on hospital-acquired influenza among patients (2012) (67)
Evaluation of high-throughput SARS-CoV-2 serological assays in a longitudinal cohort of patients with mild COVID-19: clinical sensitivity, specificity and association with virus neutralization test. (2021) (65)
Performance of influenza case definitions for influenza community surveillance: based on the French influenza surveillance network GROG, 2009-2014 (2017) (64)
Comparison of two nested PCR, cell culture, and antigen detection for the diagnosis of upper respiratory tract infections due to influenza viruses (1999) (64)
Gene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals (2010) (63)
Detection of Human Metapneumovirus RNA Sequences in Nasopharyngeal Aspirates of Young French Children with Acute Bronchiolitis by Real-Time Reverse Transcriptase PCR and Phylogenetic Analysis (2005) (61)
Herpes Simplex Virus Thymidine Kinase Mutations Associated with Resistance to Acyclovir: a Site-Directed Mutagenesis Study (2005) (61)
Phylogenetic evidence for a recent spread of two populations of human enterovirus 71 in European countries. (2010) (61)
Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic (2020) (59)
Encephalomyelitis due to human parechovirus type 1. (2002) (55)
Three ECHOvirus Serotypes Responsible for Outbreak of Aseptic Meningitis in Rhône-Alpes Region, France (2003) (54)
Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study. (2016) (54)
The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses (2011) (54)
Influenza Burden in Febrile Infants and Young Children in a Pediatric Emergency Department (2007) (52)
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 (2021) (52)
Respiratory viruses in children admitted to hospital intensive care units: Evaluating the CLART® Pneumovir DNA array†, ‡, § (2010) (52)
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France (2016) (52)
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study (2021) (49)
Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody (2020) (47)
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives (2020) (47)
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives (2020) (47)
Outbreak of acute hemorrhagic conjunctivitis in French Guiana and West Indies caused by coxsackievirus A24 variant: Phylogenetic analysis reveals Asian import (2005) (47)
Seroprevalence of varicella antibodies among pregnant women in Lyon-France (2007) (46)
Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003–2013 (2015) (46)
Cellular transcriptional profiling in human lung epithelial cells infected by different subtypes of influenza A viruses reveals an overall down-regulation of the host p53 pathway (2011) (46)
Diagnosis and surveillance of herpes simplex virus infection of the central nervous system (2000) (45)
A new material for airborne virus filtration (2011) (44)
Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020 (2020) (43)
Quality control implementation for universal characterization of DNA and RNA viruses in clinical respiratory samples using single metagenomic next-generation sequencing workflow (2018) (42)
Quantifying the role of weather on seasonal influenza (2016) (41)
Detection of cytomegalovirus in semen from a population of men seeking infertility evaluation. (1997) (41)
Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France (2020) (41)
Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particles. (2011) (40)
Molecular diversity and biennial circulation of enterovirus D68: a systematic screening study in Lyon, France, 2010 to 2016 (2018) (39)
Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study. (2017) (39)
In vitro characterization of naturally occurring influenza H3NA- viruses lacking the NA gene segment: toward a new mechanism of viral resistance? (2010) (39)
Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, France (2021) (39)
Fatal Case of Enterovirus 71 Infection and Rituximab Therapy, France, 2012 (2013) (39)
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del) (2020) (39)
Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase. (2010) (38)
Combinatorial Effect of Two Framework Mutations (E119V and I222L) in the Neuraminidase Active Site of H3N2 Influenza Virus on Resistance to Oseltamivir (2011) (38)
Blocking human enterovirus 71 replication by targeting viral 2A protease. (2012) (38)
Implementation of Alere i Influenza A & B point of care test for the diagnosis of influenza in an ED (2017) (37)
Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia (2020) (37)
Comparison of coagulase-negative staphylococci by pulsed-field electrophoresis. (1992) (37)
Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe. (2013) (36)
Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures (2018) (35)
Epidemiological and clinical characteristics of patients infected with enterovirus D68, France, July to December 2014. (2016) (35)
Influenza A Viruses Control Expression of Proviral Human p53 Isoforms p53β and Δ133p53α (2012) (35)
First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022 (2022) (35)
Genetic characterization of respiratory syncytial virus highlights a new BA genotype and emergence of the ON1 genotype in Lyon, France, between 2010 and 2014. (2018) (35)
Human parainfluenza virus type 4 infections: a report of 20 cases from 1998 to 2002. (2005) (33)
Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections. (2012) (33)
Role of Mycoplasma pneumoniae in pediatric encephalitis (2008) (33)
Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits (2014) (33)
A report on the large measles outbreak in Lyon, France, 2010 to 2011. (2012) (32)
Functional Balance between the Hemagglutinin and Neuraminidase of Influenza A(H1N1)pdm09 HA D222 Variants (2014) (32)
Fatal Influenza A(H1N1)pdm09 Encephalopathy in Immunocompetent Man (2013) (32)
Detection of rhinovirus and enterovirus in upper respiratory tract samples using a multiplex nested PCR. (2003) (32)
Detection of enteroviral sequences from frozen spinal cord samples of Japanese ALS patients (2001) (32)
Comparison of coagulase-negative staphylococci by pulsed-field gel electrophoresis (1992) (32)
A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly. (2000) (32)
Screening for Chlamydia trachomatis and Ureaplasma urealyticum infection in semen from asymptomatic male partners of infertile couples prior to in vitro fertilization. (1999) (32)
Hydroxychloroquine in the treatment and prophylaxis of SARS-CoV-2 infection in non- human primates (2020) (31)
A Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B Viruses (2014) (31)
Whole Genome Sequencing of A(H3N2) Influenza Viruses Reveals Variants Associated with Severity during the 2016–2017 Season (2019) (31)
Field Effectiveness of Pandemic and 2009-2010 Seasonal Vaccines against 2009-2010 A(H1N1) Influenza: Estimations from Surveillance Data in France (2011) (31)
Nucleolin interacts with influenza A nucleoprotein and contributes to viral ribonucleoprotein complexes nuclear trafficking and efficient influenza viral replication (2016) (30)
SARS-CoV-2 Omicron Variant, Lineage BA.1, Is Associated with Lower Viral Load in Nasopharyngeal Samples Compared to Delta Variant (2022) (30)
Évolution du taux de couverture vaccinale contre la grippe en France : de 2001 à 2006 (2008) (30)
Increased detection of Mycoplasma pneumoniae infection in children, Lyon, France, 2010 to 2011. (2012) (28)
Chest CT for rapid triage of patients in multiple emergency departments during COVID-19 epidemic: experience report from a large French university hospital (2020) (28)
Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia (2019) (28)
Detection of measles vaccine in the throat of a vaccinated child. (2002) (28)
Surveillance and impact of influenza in Europe (1999) (28)
Impact of the Respiratory Microbiome on Host Responses to Respiratory Viral Infection (2017) (27)
Baseline characteristics and clinical symptoms related to respiratory viruses identified among patients presenting with influenza-like illness in primary care (2019) (27)
Serosurveillance study on transmission of H5N1 virus during a 2006 avian influenza epidemic (2010) (27)
Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza: a prospective cohort study. (2016) (26)
Rapid bedside tests for diagnosis, management, and prevention of nosocomial influenza. (2015) (26)
Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France (2020) (26)
History of Influenza Pandemics (2008) (26)
Annexin V Incorporated into Influenza Virus Particles Inhibits Gamma Interferon Signaling and Promotes Viral Replication (2014) (26)
Emergence of enterovirus D68 clade D1, France, August to November 2018 (2019) (26)
SARS-CoV-2 viral dynamics in non-human primates (2021) (26)
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial (2020) (26)
The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies (2020) (25)
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino-acid deletion in nsp2 (Asp268Del) (2020) (25)
Cost and burden of RSV related hospitalisation from 2012 to 2017 in the first year of life in Lyon, France. (2018) (25)
Resistance of herpes simplex virus type 1 to acyclovir: thymidine kinase gene mutagenesis study. (2007) (25)
Role of bacteriophages in genomic variability of related coagulase-negative staphylococci. (1993) (25)
S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses. (2011) (25)
Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population. (2012) (25)
The NS1 Protein from Influenza Virus Stimulates Translation Initiation by Enhancing Ribosome Recruitment to mRNAs. (2017) (25)
Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors. (2008) (24)
[Cytomegalovirus research using polymerase chain reaction in Posner-Schlossman syndrome]. (2011) (24)
Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France (2021) (24)
Cerebrospinal fluid detection of enterovirus genome in ALS: A study of 242 patients and 354 controls (2010) (24)
Letter to the editor: Increase of influenza vaccination coverage rates during the COVID-19 pandemic and implications for the upcoming influenza season in northern hemisphere countries and Australia (2021) (23)
Protracted viral shedding and viral load are associated with ICU mortality in Covid-19 patients with acute respiratory failure (2020) (23)
Multicenter evaluation of the ENTEROVIRUS R-gene real-time RT-PCR assay for the detection of enteroviruses in clinical specimens. (2009) (23)
Two outbreaks of acute hemorrhagic conjunctivitis in Africa due to genotype III coxsackievirus A24 variant (2007) (23)
Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus (2021) (23)
[Sensitivity and specificity of the VIKIA Rota-Adeno immuno-chromatographic test (bioMérieux) and the ELISA IDEIA Rotavirus kit (Dako) compared to genotyping]. (2009) (23)
Recent developments with live‐attenuated recombinant paramyxovirus vaccines (2013) (23)
Effects of mutations on herpes simplex virus 1 thymidine kinase functionality: an in vitro assay based on detection of monophosphate forms of acyclovir and thymidine using HPLC/DAD. (2012) (23)
Rescue of a H3N2 Influenza Virus Containing a Deficient Neuraminidase Protein by a Hemagglutinin with a Low Receptor-Binding Affinity (2012) (23)
Influenza NS1 interacts with p53 and alters its binding to p53‐responsive genes, in a promoter‐dependent manner (2013) (22)
Specific RT-PCR procedure for the detection of human parechovirus type 1 genome in clinical samples. (2002) (22)
Novel Influenza A(H1N1) 2009 in vitro Reassortant Viruses with Oseltamivir Resistance (2010) (22)
Pediatric neurological complications associated with the A(H1N1)pdm09 influenza infection. (2011) (22)
Molecular detection and typing of influenza viruses: are we ready for an influenza pandemic? (2008) (22)
The influenza fingerprints: NS1 and M1 proteins contribute to specific host cell ultrastructure signatures upon infection by different influenza A viruses. (2012) (21)
Evaluation and comparison of PCR and hybridization methods for rapid detection of cytomegalovirus in clinical samples. (1996) (21)
Involvement of an Arginine Triplet in M1 Matrix Protein Interaction with Membranes and in M1 Recruitment into Virus-Like Particles of the Influenza A(H1N1)pdm09 Virus (2016) (21)
Enterovirus D68 nosocomial outbreak in elderly people, France, 2014 (2015) (21)
Parainfluenza virus type 5 (PIV-5) morphology revealed by cryo-electron microscopy. (2009) (21)
Complicated hospitalization due to influenza: results from the Global Hospital Influenza Network for the 2017–2018 season (2020) (21)
Novel SARS-CoV-2 Variant Derived from Clade 19B, France (2021) (20)
Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005. (2006) (20)
Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study (2020) (20)
Knowledge and risk perception of measles and factors associated with vaccination decisions in subjects consulting university affiliated public hospitals in Lyon, France, after measles infection (2014) (20)
Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season. (2011) (20)
Disseminated Rhinovirus C8 Infection with Infectious Virus in Blood and Fatal Outcome in a Child with Repeated Episodes of Bronchiolitis (2015) (20)
Metagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient Management (2018) (20)
T inflammatory memory CD8 T cells participate to antiviral response and generate secondary memory cells with an advantage in XCL1 production (2012) (19)
Incidence of H1N1 2009 Virus Infection through the Analysis of Paired Plasma Specimens among Blood Donors, France (2012) (19)
Epidemiology and burden of rotavirus diarrhea in day care centers in Lyon, France (2006) (19)
Influenza vaccine effectiveness among healthcare workers in comparison to hospitalized patients: A 2004-2009 case-test, negative-control, prospective study (2016) (19)
Characterization of naturally occurring parainfluenza virus type 2 (hPIV-2) variants. (2008) (19)
OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes (2019) (18)
Characterization of oseltamivir‐resistant influenza virus populations in immunosuppressed patients using digital‐droplet PCR: Comparison with qPCR and next generation sequencing analysis (2017) (18)
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs (2022) (18)
Immune evasion means we need a new COVID-19 social contract (2021) (18)
SARS-CoV-2: Virology, epidemiology, immunology and vaccine development (2020) (18)
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study (2021) (18)
Oseltamivir-resistant influenza A(H1N1) viruses in south of France, 2007/2009. (2010) (18)
Factors associated with admission to intensive care units in COVID-19 patients in Lyon-France (2021) (17)
Screening of the H69 and V70 deletions in the SARS-CoV-2 spike protein with a RT-PCR diagnosis assay reveals low prevalence in Lyon, France (2020) (17)
Sensibilité et spécificité du test immuno-chromatographique VIKIA ® Rota-Adéno (bioMérieux) et du kit Elisa IDEIA™ Rotavirus (Dako) par rapport aux techniques de génotypage (2009) (17)
Myocarditis and cardiac channelopathies: a deadly association? (2011) (17)
Web-based analysis of adherence to influenza vaccination among French healthcare workers. (2019) (17)
Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients (2022) (17)
The value of open-source clinical science in pandemic response: lessons from ISARIC (2021) (17)
France's COVID-19 response: balancing conflicting public health traditions (2020) (17)
Role of Cytomegalovirus Infection in the Incidence of Viral Acute Respiratory Infections in Children Attending Day-Care Centers (2001) (17)
Recommendations for respiratory syncytial virus surveillance at the national level (2021) (16)
Ex Vivo and In Vivo Inhibition of Human Rhinovirus Replication by a New Pseudosubstrate of Viral 2A Protease (2011) (16)
Non-puerperal breast infections due toStaphylococcus lugdunensis (1994) (16)
Screening and vaccination against COVID-19 to minimise school closure: a modelling study (2022) (16)
Divergent genetic evolution of hemagglutinin in influenza A H1N1 and A H1N2 subtypes isolated in the south-France since the winter of 2001-2002. (2005) (16)
Influenza increases invasive meningococcal disease risk in temperate countries. (2020) (16)
The Nonstructural NS1 Protein of Influenza Viruses Modulates TP53 Splicing through Host Factor CPSF4 (2019) (16)
Coronavirus disease 2019 attack rate in HIV-infected patients and in preexposure prophylaxis users (2020) (16)
Epidemiology and burden of rotavirus diarrhea in day care centers in Lyon, France (2007) (15)
Impact on antiviral resistance of E119V, I222L and R292K substitutions in influenza A viruses bearing a group 2 neuraminidase (N2, N3, N6, N7 and N9). (2016) (15)
Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection (2018) (15)
Use of magnetic beads versus guanidium thiocyanate-phenol-chloroform RNA extraction followed by polymerase chain reaction for the rapid, sensitive detection of enterovirus RNA. (1997) (15)
Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays (2020) (15)
Rhinoviruses, A(H1N1)v, RVS: the race for hivernal pandemics, France 2009-2010. (2009) (15)
Influenza epidemics observed in primary care from 1984 to 2017 in France: A decrease in epidemic size over time (2019) (15)
Microorganisms associated with respiratory syncytial virus pneumonia in the adult population (2018) (14)
Genetic content of Influenza H3N2 vaccine seeds (2010) (14)
Role of p53/NF-κB functional balance in respiratory syncytial virus-induced inflammation response. (2018) (14)
Influenza B burden during seasonal influenza epidemics in France. (2017) (14)
New Introductions of Enterovirus 71 Subgenogroup C4 Strains, France, 2012 (2014) (14)
Early oseltamivir therapy improves the outcome in critically ill patients with influenza: a propensity analysis (2017) (14)
Chronic bacteraemia due to Staphylococcus epidermidis after bone marrow transplantation. (1995) (14)
Practice guidelines for acute bacterial meningitidis (except newborn and nosocomial meningitis). (2009) (14)
[Evolution of influenza vaccination coverage in France from 2001 to 2006]. (2008) (13)
COVID-19 attack rate in HIV-infected patients and in PrEP users. (2020) (13)
Measurement of Enzymatic Activity and Specificity of Human and Avian Influenza Neuraminidases from Whole Virus by Glycoarray and MALDI‐TOF Mass Spectrometry (2011) (13)
Early phylodynamics analysis of the COVID-19 epidemics in France (2020) (13)
Epidemics of aseptic meningitis due to enteroviruses following national immunization days in Bahrain. (1998) (13)
Synergistic Effects of Influenza and Staphylococcus aureus Toxins on Inflammation Activation and Cytotoxicity in Human Monocytic Cell Lines (2018) (13)
Echovirus 6 strains derived from a clinical isolate show differences in haemagglutination ability and cell entry pathway. (2007) (12)
Successful H1N1 Influenza Vaccination of Children Receiving Chemotherapy for Solid Tumors (2012) (12)
Evaluation of combining upper respiratory tract swab samples with cerebrospinal fluid examination for the diagnosis of enteroviral meningitis in children (1999) (12)
Impaired glutamate uptake and EAAT2 downregulation in an enterovirus chronically infected human glial cell line (2003) (12)
Characteristics of human metapneumovirus infection in adults hospitalized for community-acquired influenza-like illness in France, 2012–2018: a retrospective observational study (2020) (12)
Beyond the influenza-like illness surveillance: The need for real-time virological data. (2011) (12)
Residual Activatability of Circulating Tfh17 Predicts Humoral Response to Thymodependent Antigens in Patients on Therapeutic Immunosuppression (2019) (12)
Immune signatures of protective spleen memory CD8 T cells (2016) (12)
Demonstration of persistent enterovirus in the pancreas of diabetic mice by in situ polymerase chain reaction. (1998) (12)
The clinical interest of HSV1 semi-quantification in bronchoalveolar lavage. (2013) (11)
Clinical severity and molecular characteristics of circulating and emerging rotaviruses in young children attending hospital emergency departments in France. (2016) (11)
Pediatric renal transplantation: A retrospective single‐center study on epidemiology and morbidity due to EBV (2018) (11)
RNA extraction and RT-PCR procedures adapted for the detection of enterovirus sequences from frozen and paraffin-embedded formalin-fixed spinal cord samples. (2003) (11)
Broad-spectrum antiviral activity of naproxen: from Influenza A to SARS-CoV-2 Coronavirus (2020) (11)
Detection of hospital outbreaks of influenza-like illness based on excess of incidence rates compared to the community. (2014) (11)
Acute flaccid myelitis caused by enterovirus D68: Case definitions for use in clinical practice. (2019) (11)
Evaluation of high-throughput SARS-CoV-2 serological assays in a longitudinal cohort of mild COVID-19 patients: sensitivity, specificity and association with virus neutralization test (2020) (11)
A major impact of the influenza seasonal epidemic on intensive care units, Réunion, April to August 2016 (2016) (10)
Ultrastructural fingerprints of avian influenza A (H7N9) virus in infected human lung cells. (2014) (10)
Mutations in the fusion protein heptad repeat domains of human metapneumovirus impact on the formation of syncytia. (2017) (10)
[Role of neuraminidase inhibitors for the treatment of influenza A virus infections]. (2010) (10)
Supplemental treatment of air in airborne infection isolation rooms using high-throughput in-room air decontamination units. (2011) (10)
Identification and characterization of a late AH1N2 human reassortant in France during the 2002-2003 influenza season. (2008) (10)
Épidémiologie et impact de la gastroentérite aiguë à rotavirus dans les crèches municipales de la ville de Lyon – saison 2004–2005 (2008) (10)
Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation, France, December 2021 - February 2022 (2022) (10)
Nutrition- and Virus-Induced Stress Represses the Expression of Manganese Superoxide Dismutase in Vitro (2004) (9)
Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial (2010) (9)
Five years of hospital based surveillance of influenza-like illness and influenza in a short-stay geriatric unit (2014) (9)
Estimation of seasonal influenza vaccine effectiveness using data collected in primary care in France: comparison of the test-negative design and the screening method. (2017) (9)
Influenza-induced acute respiratory distress syndrome during the 2010-2016 seasons: bacterial co-infections and outcomes by virus type and subtype. (2020) (9)
Influenza vaccine effectiveness among adult patients in a University of Lyon hospital (2004-2009). (2012) (9)
Infections néonatales à entérovirus en France en 2012 (2014) (9)
A race between SARS-CoV-2 variants and vaccination: The case of the B.1.1.7 variant in France (2021) (9)
Cumulative Mutations in the Genome of Echovirus 6During Establishment of a Chronic Infection in Precursors of Glial Cells (2004) (9)
Major 5′terminally deleted enterovirus populations modulate type I IFN response in acute myocarditis patients and in human cultured cardiomyocytes (2020) (9)
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR cycle amplification values (2021) (9)
Comparison of Nucleic Acid Extraction Methods for a Viral Metagenomics Analysis of Respiratory Viruses (2020) (9)
Détection par génotypage de la résistance des virus herpes simplex à l'aciclovir (2007) (9)
Influenza may facilitate the spread of SARS-CoV-2 (2020) (8)
Impact of B.1.351 (beta) SARS-CoV-2 variant on BNT162b2 mRNA vaccine effectiveness in long-term care facilities of eastern France: a retrospective cohort study (2021) (8)
Does seasonal vaccination affect the clinical presentation of influenza among the elderly? A cross-sectional analysis in the outpatient setting in France, 2003-2014. (2017) (8)
Clinical management and viral genomic diversity analysis of a child's influenza A(H1N1)pdm09 infection in the context of a severe combined immunodeficiency (2018) (8)
COVID-19: France grapples with the pragmatics of isolation (2020) (8)
Impact of the lockdown on the burden of COVID-19 in outpatient care in France, spring 2020 (2021) (8)
Delayed Start of the Respiratory Syncytial Virus Epidemic at the End of the 20/21 Northern Hemisphere Winter Season, Lyon, France (2021) (8)
Self-testing and vaccination against COVID-19 to minimize school closure (2021) (8)
[Neonatal enterovirus infections reported in France in 2012]. (2014) (7)
Complete coding regions of the prototypes enterovirus B93 and C95: Phylogenetic analyses of the P1 and P3 regions of EV‐B and EV‐C strains (2015) (7)
La résistance des virus herpès simplex aux antiviraux (1999) (7)
Engineering of a parainfluenza virus type 5 fusion protein (PIV-5 F): development of an autonomous and hyperfusogenic protein by a combinational mutagenesis approach. (2009) (7)
Incidence of asymptomatic and symptomatic influenza among healthcare workers: a multicenter prospective cohort study. (2020) (7)
Description of an influenza outbreak in a French university hospital and risk factors of nosocomial influenza (2020) (7)
Hépatite fulminante à virus Epstein-Barr : évolution favorable après transplantation hépatique (2007) (7)
Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation in France (2022) (7)
Surveillance and impact of influenza in Europe. Groupe Régional d'Observation de la Grippe and European Influenza Surveillance Scheme. (1999) (7)
Phenotypic and genotypic (pulsed-field gel electrophoresis) characteristics of enterotoxin-A-producing Staphylococcus aureus strains. (1996) (7)
Novel calixarene-based surfactant enables low dose split inactivated vaccine protection against influenza infection. (2020) (7)
Anti N1 Cross-Protecting Antibodies Against H5N1 Detected in H1N1 Infected People (2010) (7)
La génétique inverse chez les paramyxovirus : applications et perspectives (2008) (6)
Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial (2017) (6)
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19 (2022) (6)
Strain-Dependent Impact of G and SH Deletions Provide New Insights for Live-Attenuated HMPV Vaccine Development (2019) (6)
Rapid diagnosis of acute hemorrhagic conjunctivitis due to coxsackievirus A24 variant by real-time one-step RT-PCR. (2007) (6)
Premiers cas de transmission secondaire en France du nouveau virus grippal d’origine porcine A(H1N1)v (2010) (6)
Oral source ofStaphylococcus epidermidis septicemia in a neutropenic patient (1994) (6)
Viral dynamic modeling of SARS-CoV-2 in non-human primates (2020) (6)
A viral perspective on worldwide non-pharmaceutical interventions against COVID-19 (2020) (6)
Co-infection with Legionella and SARS-CoV-2, France, March 2020 (2021) (6)
H1N1 influenza A virus neuraminidase modulates infectivity in mice. (2012) (6)
Long-term use of liposomal nebulized amikacin and tedizolid for the treatment of disseminated nocardiosis after allogeneic hematopoietic stem cell transplantation (2021) (6)
Touaregs. Exil et résistance (1992) (5)
Early estimates of 2016/17 seasonal influenza vaccine effectiveness in primary care in France. (2017) (5)
Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2 (2021) (5)
Clinical and microbiological assessments of COVID-19 in healthcare workers: a prospective longitudinal study (2020) (5)
[EBV-induced fulminant hepatic failure: favorable outcome after liver transplantation]. (2007) (5)
[Amyotrophic lateral sclerosis: a role for enteroviruses?]. (2000) (5)
Epstein-Barr Virus (EBV) Reactivation, Its Treatment with Rituximab and Their Impact on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies (2016) (5)
After 2 years of the COVID-19 pandemic, translating One Health into action is urgent (2022) (5)
Complications and factors associated with severity of influenza in hospitalized children and adults during the pandemic wave of A(H1N1)pdm2009 infections--the Fluco French cohort. (2013) (5)
Epidemiological markers of coagulase-negative staphylococci (2005) (5)
[Genotyping diagnosis of acyclovir resistant herpes simplex virus]. (2007) (5)
The antiviral resistance of influenza virus (2011) (5)
Innovative Germicidal UV and Photocatalytic System Dedicated to Aircraft Cabin Eliminates Volatile Organic Compounds and Pathogenic Micro-Organisms (2014) (5)
Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model (2020) (4)
[First cases of secondary transmission of a novel swine-origin influenza A (H1N1) virus in France]. (2010) (4)
Comparison of procedures for the detection of enteroviruses in murine heart samples by in situ polymerase chain reaction. (1997) (4)
How to manage chickenpox during pregnancy: case reports. (2018) (4)
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020 (2022) (4)
Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19 (2021) (4)
A Novel I 221 L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in In fl uenza B Viruses (2014) (4)
Severe transfusion‐transmitted parvovirus B19 infection in a naive immunocompromised patient (2011) (4)
Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections (2022) (4)
High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in healthcare workers: results of the CoV-CONTACT prospective cohort (2020) (4)
Potentiel pandémique des virus influenza aviaires circulant actuellement et ayant des caractéristiques proches du virus de 1918 (2014) (4)
Characterization of a key residue for hyperfusogenic phenotype in human parainfluenza virus type 2 (hPIV-2) fusion glycoprotein (2013) (4)
Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic (2020) (3)
Human Respiratory Syncytial Virus-induced immune signature of infection revealed by transcriptome analysis of clinical pediatric nasopharyngeal swab samples (2020) (3)
Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs (2021) (3)
Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults (2022) (3)
Shedding and intestinal spread of avian influenza virus H5N2 in dabbling ducks (pre- liminary study) (2011) (3)
Impact of Pregnancy on Intra-Host Genetic Diversity of Influenza A Viruses in Hospitalised Women: A Retrospective Cohort Study (2019) (3)
Rhinovirus : principal agent des infections des voies aériennes supérieures (2004) (3)
Grippe A H1N1en unit de nonatologie: analyse et enseignements (2011) (3)
The Role of Lebanon in the COVID-19 Butterfly Effect: The B.1.398 Example (2022) (3)
It’s time to change the recommendations on COVID‐19 and human milk donations (2021) (3)
Decontamination of Intravaginal Probes Infected by Human Papillomavirus (HPV) Using UV-C Decontamination System (2019) (3)
Screening and vaccination against COVID-19 to minimize school closure (2021) (3)
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2023) (3)
Evolution of influenza genome diversity during infection in immunocompetent patients (2018) (3)
The mechanism of chronic coxsackievirus B hepatitis in rabbits. (1999) (3)
Aseptic meningitis outbreak associated with echovirus 4 in Northern Europe in 2013-2014. (2020) (3)
SARS-CoV-2 phylodynamics differentiates the effectiveness of non-pharmaceutical interventions (2020) (3)
High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort (2021) (3)
High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort (2021) (3)
Metagenomic Investigation of Torque Teno Mini Virus-SH in Hematological Patients (2019) (3)
Avian Cell Line DuckCelt®-T17 Is an Efficient Production System for Live-Attenuated Human Metapneumovirus Vaccine Candidate Metavac® (2021) (2)
Informatics assisting influenza antiviral susceptibility monitoring in Europe (2008) (2)
Azole resistance in Aspergillus fumigatus isolates from respiratory specimens in Lyon University Hospitals, France: prevalence and mechanisms involved. (2021) (2)
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial—authors’ response (2020) (2)
Description des cas confirmés de grippe A(H1N1)pdm09 admis en réanimation et identification des facteurs de gravité (2013) (2)
Optimized nested PCR enhances biological diagnosis and phylogenetic analysis of human parvovirus B19 infections (2019) (2)
OP1-1 Evaluation of sensitivity of commercial kits for the diagnosis of A(H1N1)v infection in comparison with RT-PCRs developed by national influenza centers (2009) (2)
Oral Mucositis After Allogeneic Hematopoietic Stem Cell Transplantation: Important Impact Of The Presence Of Aciclovir-Resistant Herpes Simplex Virus (HSV-1) On Its Occurrence (2013) (2)
Enterovirus genome detection in wastewater: multi centric evaluation of a commercial kit. (1999) (2)
La modulation de la signature transcriptomique de l’hôte infecté : une nouvelle stratégie thérapeutique dans les viroses graves ? Exemple de la grippe (2016) (2)
CL020 - Diversité génotypique des rotavirus aux urgences pédiatriques en France entre 2006 et 2009 (2010) (2)
Diagnostic moléculaire en pathologie infectieuse: intérêt d'un diagnostic multiplex dans les pneumopathies atypiques (1999) (2)
Estimating the impact of influenza on the epidemiological dynamics of SARS-CoV-2 (2021) (2)
Rapport basé sur une enquête microbiologique et sur la littérature existante. Etiologie virale des rhinopharyngites et otites aiguës de l'enfant. Résultats d'une enquête prospective (ORPHE) hiver 1995–96* (1997) (2)
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates (2020) (2)
Metagenomic Analysis Reveals High Abundance of Torque Teno Mini Virus in the Respiratory Tract of Children with Acute Respiratory Illness (2022) (2)
Which sample for the transport of mycoplasma, eSwab® or dry swab? (2019) (2)
[Avian influenza in children]. (2009) (2)
[Pandemic potential of circulating avian influenza strains sharing common features with the 1918 influenza strain]. (2014) (2)
[Influenza A H1N1 in neonatal intensive care unit: analysis and lessons]. (2011) (2)
Surveillance des entérovirus en France métropolitaine , 2000-2004 (2)
Outbreak of aseptic meningitis in Djibouti in the aftermath of El Niño. (2003) (2)
Analytical Performances of the Panther Fusion System for the Detection of Respiratory Viruses in the French National Reference Centre of Lyon, France (2020) (2)
Remdesivir for the Treatment of Hospitalised Patients with COVID-19 (DisCoVeRy): A Randomised, Controlled, Open-Label Trial (2021) (2)
Vaginal Neoplasia Induced by an Unusual Papillomavirus Subtype in a Woman with Inherited Chromosomally Integrated Human Herpesvirus Type 6A (2017) (2)
Grippe et antiviraux (2011) (1)
Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits (2013) (1)
The non-structural NS 1 protein of influenza viruses modulates TP 53 splicing through the host factor (2019) (1)
Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study (2022) (1)
[Modulation of transcriptomic signature of the infected host: a new therapeutic strategy for the management of severe viral infections? Example of the flu]. (2016) (1)
Description clinicovirologique du syndrome pieds-mains-bouche en France : étude observationnelle prospective multicentrique 2010–2011 (2011) (1)
Clinical and phylogenetic influenza dynamics for the 2019-20 season in the global influenza hospital surveillance network (GIHSN) - Pilot study. (2022) (1)
Influenza Increases Invasive Meningococcal Disease Risk in Temperate Countries (2019) (1)
Virus émergents ou menaces à répétition (2005) (1)
Differences in HADS and SF-36 scores 1 year after critical illness in COVID-19 patients (2022) (1)
Long-term humoral response following simultaneous Delta and Omicron BA.1 co-infection (2022) (1)
Chronic use of renin‐angiotensin‐aldosterone system blockers and mortality in COVID‐19: A multicenter prospective cohort and literature review (2021) (1)
Investigation of Vaccine Breakthrough Infections by Vaccine strategy during the Delta Variant Wave in France (2021) (1)
24es Rencontres du Groupe d'expertise et d'information sur la grippe (GEIG, www.grippe-geig.com). (2011) (1)
Metagenomic analysis of the respiratory virome associated with acute respiratory illness of unknown etiology in infants (2016) (1)
Update – Swine-origin triple reassortant influenza A ( H 3 N 2 ) variant viruses in North America 17 August 2012 (2012) (1)
Linking influenza epidemic onsets to covariates at different scales using a dynamical model (2018) (1)
University of Dundee Influenza A viruses alter the stability and antiviral contribution of host E 3-ubiquitin ligase Mdm 2 during the time-course of infection (2018) (1)
Herpes simplex meningitis after surgical removal of a clivus chordoma (1997) (1)
[New pandemic influenza: what are the risks?]. (2008) (1)
Live virus neutralization testing in convalescent and vaccinated subjects against 19A, 20B, 20I/501Y.V1 and 20H/501.V2 isolates of SARS-CoV-2 (2021) (1)
Paralytic poliomyelitis associated with the Sabin 3 revertant strain of poliovirus in Bahrain (2001) (1)
[Enterovirus-related pericarditis and mediastinitis after heart surgery: a case report]. (2008) (1)
Trivalent-Inactivated Influenza Vaccine Effectiveness Against Hospitalized Influenza in France During 2014–2015 Winter: Results From the FLUVAC Study (2015) (1)
Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients (2022) (1)
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study (2022) (1)
Épidémiologie de A (H1N1 ) 2009 en France fin décembre 2009: bilan et prévisions (2010) (1)
Correction: Impact of Pregnancy on Intra-Host Genetic Diversity of Influenza A Viruses in Hospitalised Women: A Retrospective Cohort Study. J. Clin. Med. 2020, 9, 1974 (2019) (1)
Burden of critically ill patients with influenza in a French catchment population (2021) (1)
Estimation of influenza-attributable burden in primary care from season 2014/2015 to 2018/2019, France (2021) (1)
[Description of patients with confirmed influenza A(H1N1)pdm09 admitted to an intensive care unit and identification of severity risk factors]. (2013) (1)
Five years of hospital based surveillance of influenza-like illness and influenza in a short-stay geriatric unit (2014) (1)
Differential virological diagnosis of acute respiratory infections in suspect SARS patients (2004) (1)
Characterization and impact of respiratory microbiota on viral infections. (2018) (1)
Pertinence du diagnostic virologique des infections respiratoires communautaires (2003) (1)
Cas de pneumopathie nécrosante communautaire secondaire à la surinfection d'une grippe saisonnière H1N1 par un streptocoque invasif du groupe A (2010) (1)
Caractérisation et impact du microbiote bactérien respiratoire sur les maladies virales (2018) (1)
La balance HA-NA des virus influenza A(H1N1). (2016) (1)
Vaccin antigrippal en situation d'émergence. (2014) (1)
R-02 Neuf annes de surveillance des entrovirus en France (2009) (1)
Apport du laboratoire dans le diagnostic des infections à virus herpès simplex (1998) (1)
Quel est le risque d'une nouvelle pandémie grippale? (2008) (1)
Grippe aviaire chez l’enfant (2009) (1)
Influenza A(H1N1)2009 epidemic in France: virological parameters. (2010) (1)
Development of robust and innovative vaccine effectiveness WP 7 – Influenza Vaccine Effectiveness Pilot Studies Lead contributor (2018) (1)
SRAS (2004) (1)
[Avian influenza causes fear about a pandemic]. (2004) (0)
Investigation of vaccine breakthrough infections by vaccination scheme during the Delta variant wave in France (2022) (0)
Structure of the Neuraminidase from the B/Brisbane/60/2008 virus. (2014) (0)
Characterization of oseltamivir-resistant population dynamics in immunosuppressed patients with prolonged excretion using ddPCR platform and comparison with deep sequencing analysis (2016) (0)
ORIGINAL IN-SILICO APPROACH IDENTIFIES NEW BROAD-SPECTRUM INFLUENZA A ANTIVIRALS (2010) (0)
C-2 Insight into influenza A(H1N1) (2009) (0)
Vaginal intraepithelial neoplasia induced by unusual papillomavirus subtype associated with high load of human herpes virus 6 (2016) (0)
Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination (2023) (0)
Characterization of the genome diversity of influenza virus associated with severe form of influenza in children (2015) (0)
Publisher Correction: Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study (2021) (0)
[Why must we vaccinate and get vaccinated against flu!]. (2013) (0)
Genomic evolution of SARS-CoV-2 in Reunion Island (2022) (0)
Rapid and reliable inactivation protocols for the diagnostics of emerging viruses: The example of SARS‐CoV‐2 and monkeypox virus (2022) (0)
Arabinogalactanes, apiogalacturonanes and heteroglycans sulphate for the treatment of diseases caused by influenza virus (2011) (0)
Biographie et Bibliographie de Jean-Jacques Rousseau (2015) (0)
[Necrotizing community-acquired pneumonia secondary to influenza a (H1N1) super-infected by an invasive group A streptococcus]. (2010) (0)
Management of Influenza Virus Infections (Orthomyxoviridae) (2021) (0)
Evaluation of a multiplex gastrointestinal panel. Which test for a pediatric population (2015) (0)
Characterization of a key residue for hyperfusogenic phenotype in human parainfluenza virus type 2 (hPIV-2) fusion glycoprotein (2013) (0)
Level of maternal antibodies against respiratory syncytial virus (RSV) nucleoprotein at birth and risk of RSV very severe lower respiratory tract infection (2022) (0)
Oseltamivir Prophylaxis Does Not Prevent the Development of Immune Responses to Influenza (2008) (0)
924. Incidence of Symptomatic and Asymptomatic Influenza Among Healthcare Workers: A Multicenter Prospective Cohort Study (2018) (0)
RESPIR-08 - Facteurs associés à la gravité d’une grippe confirmée chez des adultes hospitalisés en France de 2012 à 2015 : une étude prospective multicentrique (2016) (0)
Characterization of Influenza Viruses Responsible for Acute Respiratory Illness in Cambodia from 2015 to 2016 (2020) (0)
Les caractéristiques des patients atteints d’infection à SARS-CoV-2 influencent-elles leur délai d’admission en hospitalisation ? (2020) (0)
Impact of Single or Associated CMV, EBV and BK Virus Reactivation Early after Allogeneic Hematopoietic Stem Cell Transplantation on Relapse Incidence (2014) (0)
In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017–2019: an observational study (2021) (0)
I (Influenza) will be back! (2018) (0)
Human infections caused by A (H7N9) influenza virus: emergence, evolution and pandemic risk. (2017) (0)
Les enjeux sanitaires, point de vue (2022) (0)
Viral genomic diversity: Characterization and consequences on respiratory infections virulence. (2018) (0)
Novel antiviral compounds and combination therapy for influenza viruses. (2019) (0)
Thérapeutique et vaccination antigrippale (2019) (0)
A five year survey of respiratory syncytial virus infections in outpatients (1997) (0)
FP697ACTIVABILITY OF CIRCULATING TFH17 PREDICTS HUMORAL RESPONSE TO THYMUS-DEPENDENT ANTIGENS (2018) (0)
Immunity to SARS-CoV-2 in a Dialyzed Patient Who Developed COVID-19 Twenty Days After the Second Dose of BNT162b2 Vaccine: a Case Report (2021) (0)
Two outbreaks of acute hemorrhagic conjunctivitis in Africa due to genotype III coxsackievirus variant A24 (2007) (0)
Facing the influenza challenge (2016) (0)
O.7.4 Detection of neuraminidase cross-protection antibodies against H5N1 in H1N1 infected or vaccinated humans (2009) (0)
Influenza virus epidemiology: a permanent vaccine challenge. (2019) (0)
Is it possible to predict influenza antigenic variants? (2017) (0)
Clinical characteristics and factors associated with admission to intensive care units inhospitalized COVID-19 patients in Lyon University Hospitals, France (2020) (0)
Identifying the Target Population for Primary Respiratory Syncytial Virus Two-Step Prevention in Infants: Normative Outcome of Hospitalisation Assessment for Newborns (NOHAN) (2022) (0)
Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection (2018) (0)
Variants de hpiv-2,et leurs applications medicales (2008) (0)
First case of an exceptional Zona of the popliteal fossa (2020) (0)
OP4-3 Molecular detection of respiratory viruses: routine application on 522 samples taken in children less than 2 year old (2009) (0)
Severe fetopathy caused by cytomegalovirus recurrence with isolated intra-abdominal complication in an immune woman (2016) (0)
Quelles alternatives à la fermeture des écoles pour la transmission de la grippe (2014) (0)
Evaluation of Routine Serological Diagnostic Methods for the 2009 Pandemic Inﬂuenza A (H1N1) Virus (2014) (0)
Cross-boarder surveillance of enterovirus-D68 in Europe during the 2014 North-American outbreak (2015) (0)
P.066 Consequences of combinations of mutations in the neuraminidase active site on the cell surface expression, the activity and the sensibility of the neuraminidase to the neuraminidase inhibitors (2009) (0)
SARS-CoV-2 spike 340 and 337 mutations in Omicron variants are selected after Sotrovimab infusion in immunocompromised patients (2022) (0)
The NS Segment of H1N1pdm09 Enhances H5N1 Pathogenicity in a Mouse Model of Influenza Virus Infections (2018) (0)
Description of an influenza outbreak in a French university hospital and risk factors of nosocomial influenza (2020) (0)
Evolution des virus influenza A (2004) (0)
RHINOVIRUSES, A(H1N1)v, RSV: THE RACE FOR HIVERNAL PANDEMICS, FRANCE 2009-2010. Author's reply (2009) (0)
O.7.1 Gene expression analysis of cells infected with different human and avian influenza A virus strains (2009) (0)
O76 Syndrome grippal: complications chez les patients diabétiques ou obèses (2015) (0)
Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018 (2020) (0)
Synergistic effect, in human monocytic cell-lines, of Influenza and Staphylococcus aureus on inflammation activation and cytotoxicity (2015) (0)
Management of diabetic foot infections (2004) (0)
Les virus de la grippe ; peste aviaire, grippe porcine et risques humains (2010) (0)
Diagnostic virologique de la grippe (2002) (0)
Molecular and clinical characterization of Enteroviruses-D68 infections between 2010 and 2015 in Lyon, France using 3D Cell culture and Next-Generation Sequencing (2016) (0)
CO-02: Syndromes grippaux chez les diabétiques en milieu hospitalier : caractéristiques et complications (2016) (0)
Et les virus respiratoires ! (2004) (0)
V-07 Infections materno-fœtale à Parvovirus B19 : expérience de 2005 à 2009 aux hospices civils de Lyon (2009) (0)
[Epidemiology of A (H1N1) 2009 in France as of December 2009: summary and forecast]. (2010) (0)
22es Rencontres du Groupe d’expertise et d’information sur la grippe (2009) (0)
Are R292K, E119V and I222L substitutions associated with antiviral resistance in all Influenza virus subtypes within group 2 neuraminidases (N3, N6, N7, and N9)? (2015) (0)
J-07 - Saison grippale 2012-2013 : 3 virus pour une épidémie (2013) (0)
P.060 Influenza A viruses host ultrastructural nuclear modifications: specific different patterns between avian and human strains? (2008) (0)
Surveillance de la grippe à Mayotte : vers une adaptation des recommandations vaccinales ? (2020) (0)
La pandémie H1N1, des prévisions à la réalité (2010) (0)
SARS-CoV-2 genetic diversity: Its impact on vaccine efficacy (2022) (0)
Caractérisation du site d'attachement (attP) du bactériophage 118II de Staphylococcus epidermidis (1994) (0)
Avis relatif au protocole sanitaire renforcé proposé pour les restaurants dans le contexte de la pandémie de Covid-19 (HCSP, Avis et Rapports) (2020) (0)
Les antiviraux dans la grippe: mécanismes d'action et phénomènes de résistance (2000) (0)
Comment se présente la grippe chez les seniors vaccinés (2017) (0)
OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes (2019) (0)
Notion de clone et epidemiologie (1990) (0)
Grippe H5N1 : historique et potentiel pandémique (2012) (0)
9 e congrès annuel de la Société européenne de virologie clinique (2007) (0)
Caractéristiques à l’admission des patients COVID-19 hospitalisés : étude observationnelle, prospective et multicentrique dans un centre hospitalier universitaire (2020) (0)
Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Oseltamivir (2014) (0)
MÉTHODES UTILISÉES POUR LA SURVEILLANCE DES ENTÉROVIRUS (2005) (0)
[Antagonists of PAR1: towards a new antiviral strategy against flu]. (2013) (0)
Using wearable electronic sensors for assessing contacts between individuals in various environments (2011) (0)
U-04 La rougeole, quel risque pour les patients hospitalisés ? Une étude de la séroprévalence des patients hospitalisés à Lyon de 2005 à 2008 (2009) (0)
Clinique et diagnostic de la grippe saisonnière (2019) (0)
Title : Clinical severity and molecular characteristics of circulating and 1 emerging rotaviruses in young children attending hospital emergency 2 departments in France (2016) (0)
Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus (2014) (0)
[Not Available]. (2016) (0)
Caractéristiques cliniques et facteurs associés à l’admission en unités de soins intensifs chez des patients COVID-19 hospitalisés (2020) (0)
A multidrug resistant HSV1 infection occurring under cidofovir treatment for ADV infection in an immunocompromised child: Perspectives to new antiviral drugs (2016) (0)
Antagonistes de PAR1 - Vers une nouvelle stratégie de lutte contre la grippe (2013) (0)
M-01 Parvovirus B19 : bilan de 4 ans de sérologies et de biologie moléculaire (2009) (0)
H7N9 flu (2014) (0)
La négativité persistante des prélèvements nasopharyngés est-elle fiable pour éliminer une pneumonie au SARS-CoV-2 chez un patient en quarantaine post-exposition ? (2020) (0)
Les Parechovirus : biologie, épidémiologie et diagnostic (2003) (0)
[23es Rencontres du Groupe d'expertise et d'information sur la grippe (GEIG, www.grippe-geig.com)]. (2011) (0)
COL4-01 Étonnants virus influenza : bilan de deux années de grippe saisonnière à surprise (2009) (0)
Long-term humoral response following Delta and Omicron BA.1 co-infection (2023) (0)
Influenza B in the general population. Retrospective analysis of French surveillance data from 2003 to 2017 (2018) (0)
[Emergent viruses and/or repeated threats]. (2005) (0)
[Toward universal influenza vaccines?] (2016) (0)
Viral Reactivation in Acute Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission: Stimulation of the Immune System (2020) (0)
Novel antiviral compounds and combination therapy for influenza viruses. (2019) (0)
Virological methods for the diagnosis of herpes simplex virus infections (1998) (0)
Excess cases of Influenza like illnesses in France synchronous with COVID19 invasion. (2020) (0)
Processes to optimize viral production by inactivating or inhibiting HIPK2 and gene modified cells for viral production (2010) (0)
La grippe avivaire réveille la peur d'une pandémie (2004) (0)
Respiratory Syncytial Virus Infection in Adults Hospitalized with Influenza-like illness in France. (2016) (0)
Application of a forecasting model to mitigate the consequences of unexpected RSV surge: Experience from the post-COVID-19 2021/22 winter season in a major metropolitan centre, Lyon, France (2023) (0)
The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative (2022) (0)
Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19 (2023) (0)
T inflammatory memory CD8 T cells participate to antiviral response and generate secondary memory cells with an advantage in XCL1 production (2012) (0)
A novel effective live-attenuated human metapneumovirus vaccine candidate produced in the serum-free suspension DuckCelt®-T17 cell platform (2021) (0)
O.1.6 Viral glycoprotein-mediated cell fusion assay using nano-particles: a new characterization tool for enveloped viruses (2009) (0)
D-05 Impact des formations « Grippe Aviaire » sur la connaissance du plan pandémique par les professionnels de santé (2008) (0)
Effect of influenza vaccination among healthcare workers on hospital-acquired influenza in short-stay hospitalized patients: A multicenter pilot study in France (2022) (0)
28: Apports de la détection et du génotypage des HPV cutanés au CHU de Lyon (2010) (0)
[Antivirals in influenza: mechanism of action and the resistance phenomenon]. (2000) (0)
Nosocomial influenza in paediatric services at Edouard Herriot University Hospital, Lyons, France, winters 2005-2006 and 2006-2007. (2009) (0)
Immuniser Lyon : un programme inédit de promotion et d’incitation à la vaccination avril 2015–juin 2016 (2017) (0)
Structure of the Neuraminidase from the B/Brisbane/60/2008 virus in complex with Oseltamivir (2014) (0)
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 (2022) (0)
[Reverse genetic in paramyxovirus]. (2008) (0)
Clotting Activity inStaphylococcus schleiferi Subspecies from HumanPatients (1994) (0)
Influenza and antiviral agents (2011) (0)
OP3-1 Evaluation of Clart® Pneumovir DNA arrays for the detection of respiratory viruses among children hospitalised in intensive care unit (2009) (0)
O023: Combining electronic contacts data and virological data for studying the transmission of infections at hospital (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bruno Lina?

Bruno Lina is affiliated with the following schools:

École normale supérieure de Lyon
Claude Bernard University Lyon 1

Bruno Lina's Academic­Influence.com Rankings

Why Is Bruno Lina Influential?

Bruno Lina's Published Works

Published Works

What Schools Are Affiliated With Bruno Lina?

Bruno Lina's AcademicInfluence.com Rankings